Leonor Almeida Selected Research

3,4-Dihydroxyphenylacetic Acid

9/2011	Nitric oxide and DOPAC-induced cell death: from GSH depletion to mitochondrial energy crisis.
11/2008	3,4-Dihydroxyphenylacetic acid (DOPAC) modulates the toxicity induced by nitric oxide in PC-12 cells via mitochondrial dysfunctioning.
8/2005	Synergistic inhibition of respiration in brain mitochondria by nitric oxide and dihydroxyphenylacetic acid (DOPAC). Implications for Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leonor Almeida Research Topics

Disease

4	Inflammation (Inflammations) 03/2019 - 02/2013
3	Mitochondrial Diseases (Mitochondrial Disease) 09/2011 - 08/2005
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2019 - 02/2013
2	Neoplasms (Cancer) 09/2004 - 03/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Infections 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	HIV Infections (HIV Infection) 01/2016
1	Heart Failure 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Respiratory Insufficiency (Respiratory Failure) 01/2016
1	Diabetes Mellitus 01/2016
1	Liver Failure 01/2016
1	Melanoma (Melanoma, Malignant) 01/2012
1	Hemolysis 03/2002

Drug/Important Bio-Agent (IBA)

4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 11/2008
3	CytokinesIBA 03/2019 - 02/2013
3	PolyphenolsIBA 03/2019 - 02/2013
3	3,4-Dihydroxyphenylacetic AcidIBA 09/2011 - 08/2005
3	Dopamine (Intropin)FDA LinkGeneric 09/2011 - 08/2005
2	AcidsIBA 11/2008 - 08/2005
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2004 - 03/2002
1	osimertinibIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 03/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 01/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	FlavonoidsIBA 01/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2017
1	LuteolinIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	CaspasesIBA 11/2008
1	Cytochromes c (Cytochrome c)IBA 11/2008
1	Caspase 3 (Caspase-3)IBA 11/2008
1	Caspase 9IBA 11/2008
1	Photosensitizing Agents (Photosensitizers)IBA 03/2002
1	AntioxidantsIBA 03/2002
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2002
1	Lipoproteins (Lipoprotein)IBA 03/2002
1	caffeic acidIBA 03/2002

Therapy/Procedure

2	Therapeutics 01/2017 - 02/2013
2	Photochemotherapy (Photodynamic Therapy) 09/2004 - 03/2002
1	Length of Stay 01/2018
1	Prostheses and Implants (Prosthesis) 01/2018
1	Cryotherapy (Therapy, Cold) 01/2012